The 11th Open Symposium of the EIP will highlight current hot topics in the immunogenicity area.

As a participant, you will learn about immunogenicity of novel gene therapies, multi-domain biologics, regulatory expectations, innovative ADA assay approaches and latest achievements in respect to prediction of an ADA response.

Our organizing committee succeeded in attracting high class speakers from academia, leading biopharmaceutical companies/CROs and regulatory authorities. A dedicated workshop day and a panel discussion will provide you with a plenty of opportunities to directly address your questions to experts in the field.

Finally, registration to our scientific conference also includes an invitation to our famous local social evening event with great additional occasions for networking.

Looking forward seeing you in Lisbon,

Daniel Kramer, EIP Chairman